Financial News Feed

Today ACAD ranks # as HOLD CANDIDATE.
Today ACAD ranks # as HOLD CANDIDATE.

ACAD stock ACADIA Pharmaceuticals Inc.

ACAD stock
ACADIA Pharmaceuticals Inc.

When conducting stock research, investors may want to take a look at what the covering analysts are saying about the company. Zacks Research provides an average broker rating which is compiled using p...

Read more

Watching some recent stock price activity for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), we have seen shares trading near the $21.07 level. Investors have a wide range of tools at their disposal when ...

Read more

ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday. T...

Read more

The Earnings to Price yield of Arrow Electronics, Inc. (NYSE:ARW) is 0.084374. This is calculated by taking the earnings per share and dividing it by the last closing share price. This is one of the m...

Read more

AcadeMedia AB (ACAD) Dips -0.76% on Jan 17
10:02pm, Thursday, 17'th Jan 2019
Shares of AcadeMedia AB (STO:publ) last traded at 45.95, representing a move of -0.76%, or -0.35 per share, on volume of 82,002 shares. After opening the trading day at 46.3, shares of AcadeMedia AB t...

Read more

Investors sentiment decreased to 0.92 in 2018 Q3. Its down 0.30, from 1.22 in 2018Q2. It turned negative, as 31 investors sold ACAD shares while 45 reduced...

Read more

ACADIA Pharmaceuticals Inc. (NasdaqGS:ACAD) has a Piotroski F-Score of 3 at the time of writing. The F-Score may help discover companies with strengthening balance sheets. The score may also be used t...

Read more

Studying shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), we note that performance has not been great over the last year. During that time, shares have slid -25.95%. The investing community will b...

Read more

Investing in the stock market has traditionally offered bigger returns than other types of investments. Along with the opportunity for higher returns comes a higher amount of risk. Stocks can be expos...

Read more

BidaskClub upgraded shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) from a hold rating to a buy rating in a research note published on Thursday. ACAD has been the topic of a number of other research re...

Read more

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of ACADIA Pha...

Read more

Investors sentiment decreased to 0.92 in Q3 2018. Its down 0.30, from 1.22 in 2018Q2. It turned negative, as 31 investors sold ACADIA Pharmaceuticals Inc. shares while 45 reduced holdings. 31 funds op...

Read more

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Director Laura Brege sold 10,000 shares of the stock in a transaction that occurred on Wednesday, January 9th. The shares were sold at an average price of $20...

Read more

ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday. ACAD has been the s...

Read more

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a compan...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank